FDLI: Drug Quality and Security in 2016 January 26, 2016 | Washington, DC

Drug Quality and Security in 2016 

January 26, 2016 | Washington, DC

In 2013 the Drug Quality and Security Act was signed into law in an effort to increase the quality of the US drug supply. As industry implements new requirements, questions on office use, traceability, serialization, preemption, and licensing persist. Join us to hear from key regulators, and discuss the ongoing implementation of the Compounding Quality Act, the Drug Supply Chain Security Act (DSCSA), and recent FDA guidance.